GS Investments’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
GS Investments's LLY Position: Q1 2026 in Review
GS Investments increased its Eli Lilly (LLY) stake by 0.43% in Q1 2026, buying an estimated $13.2K and bringing the position to 3,015 shares worth $2.77M. The position accounts for 1.59% of the portfolio, ranked #25.
GS Investments first reported a position in LLY in Q1 2025 and has held it in 5 quarters since. The position peaked at $3.23M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- GS Investments held 3,015 shares of Eli Lilly worth $2.77M as of Q1 2026.
- GS Investments bought 13 Eli Lilly shares in Q1 2026, an estimated $13.2K.
- Eli Lilly made up 1.59% of GS Investments's portfolio in Q1 2026, its #25 holding.
- GS Investments first reported a position in Eli Lilly in Q1 2025 and has held it in 5 quarters since.
- GS Investments's Eli Lilly position peaked at $3.23M in Q4 2025.
- 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on GS Investments's 13F filing for Q1 2026, filed 6 May 2026.